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Background 44 
Although periodic chlamydia and gonorrhea testing is recommended for men who have sex 45 
with men (MSM), little is known about testing rates in China. This study examines chlamydia 46 
and gonorrhea testing rates and testing correlates among Chinese MSM.   47 
 48 
Methods  49 
An online survey of MSM was conducted in August 2017. Men aged 16 years or above who 50 
had ever had sex with a man were enrolled through a gay social networking mobile 51 
application. We asked men about their sexual behaviors, community engagement in sexual 52 
health, and previous testing for chlamydia, gonorrhea and HIV. Multivariable logistic 53 
regressions were used to examine the association of testing with community engagement and 54 
recent HIV testing.   55 
 56 
Results 57 
Of 1031 men, 819 (79.5%) were under 30 years of age, and 263 (25.5%) reported condomless 58 
sex in past three months. In total, 294 (28.5%) men tested for chlamydia, 315 (30.6%) men 59 
tested for gonorrhea, and 817(79.2%) men tested for HIV. One hundred and twenty-five 60 
(42.5%) men who received chlamydia testing and 134 (42.5%) men who received  61 
gonorrhea testing had substantial community engagement. Compared to men with 62 
no/minimal community engagement, men with substantial community engagement had 63 
greater odds of chlamydia testing (adjusted odds ratio [AOR] =2.8, 95%CI: 1.9-4.3) and 64 
gonorrhea testing (AOR=2.9, 95%CI: 2.0-4.4). Men with recent HIV testing were more likely 65 
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to have received chlamydia testing (AOR=1.5, 95%CI: 1.1-2.0) and gonorrhea testing 66 
(AOR=1.6, 95%CI: 1.2-2.1).   67 
 68 
Conclusions 69 
Chlamydia and gonorrhea testing levels are low among Chinese MSM. Integrating chlamydia 70 
and gonorrhea test promotion strategies into HIV prevention programs that engage MSM 71 
communities may help bridge the gap.     72 
 73 
Summary  74 
We found low chlamydia and gonorrhea lifetime testing rates among MSM in China and 75 
integrated STI/HIV testing programs that engage MSM may improve lifetime chlamydia and 76 
gonorrhea test uptake.  77 
 78 
Keywords: chlamydia test; gonorrhea test; men who have sex with men; China 79 
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INTRODUCTION 87 
Chlamydia and gonorrhea are the most common bacterial sexually transmitted diseases 88 
(STDs) worldwide.[1] Men who have sex with men (MSM) are at particularly high risk for 89 
infection. In China, prevalence estimates among MSM range from 8.0-24.0% for chlamydia, 90 
and 1.5-2.7% for gonorrhea.[2] Chlamydia and gonorrhea infection increase the risk of both 91 
transmitting and acquiring HIV,[3-5] and the rate of coinfection with HIV is high.[6] In 92 
addition to the risk of transmitting chlamydia and gonorrhea to male sex partners, MSM may 93 
also be a bridge for transmitting the two infections to their female sex partners. A previous 94 
study showed that up to 26.3% of Chinese MSM had recent sexual intercourse with women 95 
and only 25.6% consistently used condoms with female sex partners in the last six months.[7] 96 
Further, antimicrobial resistance (AMR) is becoming a global concern, and treatment options 97 
for drug-resistant gonorrhea strains are increasingly limited.[8] Early diagnosis and 98 
prevention of further transmission are crucial for controlling the spread and impact of drug-99 
resistant gonorrhea.[9]  100 
WHO guidelines suggest that if the prevalence of asymptomatic urethral and rectal chlamydia 101 
and gonorrhea infections is over 1-2%, the benefits of periodic testing for these two 102 
infections among MSM outweigh the harms and costs.[10] However, current STI control 103 
efforts are focused on controlling HIV and syphilis in most resourced limited low- and 104 
middle-income countries, including China. China has no guidelines for chlamydia and 105 
gonorrhea testing among MSM, and chlamydia is not a reportable STI. The expense of 106 
nucleic acid amplification tests for gonorrhea and chlamydia may also discourage testing.[10]  107 
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Given that China’s universal healthcare system has many competing priorities with limited 108 
health resources, optimal gonorrhea and chlamydia testing frequency for Chinese MSM 109 
remains unknown. Periodic chlamydia and gonorrhea testing recommended by the WHO may 110 
be a challenging strategy for the country. However, it is also unwise to neglect the two 111 
infections among Chinese MSM due to the high prevalence in this group. Other less 112 
complicated and costly alternative screening strategies in MSM may be worth consideration, 113 
such as testing chlamydia and gonorrhea at least once in sexually active young MSM.  114 
 115 
We conducted a cross-sectional survey among MSM recruited online from Guangdong and 116 
Shandong Provinces in China. The purpose of this study is to examine self-reported 117 
chlamydia/gonorrhea testing rates and factors associated with testing among a Chinese MSM 118 
population.  119 
 120 
MATERIALS AND METHODS  121 
Sampling  122 
We conducted an online survey of 1,031 MSM in August 2017. We recruited men through a 123 
gay social networking dating app, Blued, by sending a survey invitation to registered users in 124 
eight Chinese cities (Guangzhou, Shenzhen, Zhuhai, and Jiangmen in Guangdong Province; 125 
Jinan, Qingdao, Yantai and Jining in Shandong Province). In both provinces, HIV and 126 
syphilis testing services are promoted in MSM but chlamydia and gonorrhea testing are only 127 
recommended among symptomatic men. Eligibility criteria for our study included the 128 
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following: 1) biologically male at birth, 2) 16 years old or above, 3) reported ever having anal 129 
sex with men, and 4) HIV negative or unknown HIV status. All survey data were anonymous 130 
and confidential, and online consent was obtained before the commencement of the survey. 131 
An incentive of 7.5 USD (50 Chinese Yuan) mobile phone top-up was provided to all 132 
participants.   133 
Measures 134 
We collected information about participants’ sociodemographic characteristics including age, 135 
residence, marital status, highest education obtained, and annual income. We also collected 136 
sexual history, including sexual orientation (gay, bisexual/unsure), sexual orientation 137 
disclosure to healthcare providers (yes/no), and whether they had condomless sex with either 138 
men or women in past three months (yes/no). We obtained information about ever testing for 139 
HIV, syphilis, chlamydia or gonorrhea (yes/no), and their HIV testing in the past three months 140 
(yes/no). Community engagement was measured using a six-item construct validated in 141 
Chinese MSM. [11]  These questions assessed whether men had (1) discussed HIV/STI 142 
testing or sexual health online, (2) awareness of ongoing sexual health community events, (3) 143 
encouraged someone to get tested for HIV/STDs, (4) accompanied someone to get tested for 144 
HIV/STDs, (5) volunteered to help provide sexual health services, or (6) helped organize a 145 
sexual health campaign. Participants who answered “yes” to items (1) and/or (2) were 146 
considered to have “minimal engagement”; (3) and/or (4) to have “moderate engagement”, 147 
and (5) and/or (6) to have “substantial engagement”.[11] Participants who answered yes to 148 
multiple items were categorized into the level of engagement corresponding with the highest 149 
item number. Participants did not answer “yes” to any items were considered to have no 150 
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engagement.  151 
We also measured anticipated HIV stigma[12] and HIV testing self-efficacy.[13] The 7-item 152 
anticipated HIV stigma scale asked participants about their own feelings about themselves if 153 
they had HIV as well as perceived discriminating attitudes from other people. For example, 154 
men were asked to rate level of agreement with “If I had HIV, I’d worry about people 155 
discriminating against me”. HIV testing self-efficacy was measured using a six-item scale, 156 
measuring men’s confidence about HIV testing. For example, we asked them about the level 157 
of agreement with “You have confidence that you will undergo HIV testing regularly”. We 158 
used a four-point Likert format: strongly disagree (1), disagree (2), agree (3), strongly agree 159 
(4) for responses to above scales. Scores for anticipated HIV stigma and self-efficacy ranged 160 
from 1 to 4. A higher score indicated a higher level of anticipated stigma or better self-161 
efficacy.  162 
Statistical analysis 163 
Descriptive analysis was used to describe sample characteristics, including sociodemographic 164 
backgrounds, sexual behaviors, HIV, syphilis, chlamydia and gonorrhea testing, anticipated 165 
HIV-related stigma, HIV testing self-efficacy, and community engagement. Chi-squared tests 166 
or independent samples t-tests were conducted to examine differences in characteristics 167 
between testers and never testers for chlamydia and gonorrhea.  168 
We carried out multivariable logistic regression analyses to examine factors associated with 169 
chlamydia and gonorrhea testing behaviors, controlling for age, marital status, education, 170 
annual income and province. No engagement and minimal engagement were grouped as one 171 
category for regression analysis due to small cell numbers. We reported odds ratios, 95% 172 
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confidence intervals (CIs) and p values. A p-value of <0.05 was considered statistically 173 
significant. Data were analyzed using SPSS, version 25. 174 
Ethical statement 175 
Ethical approval was obtained from the institutional review committees at the Dermatology 176 
Hospital of Southern Medical University (14-1865) and the University of North Carolina at 177 
Chapel Hill (1R01AI114310) prior to the launch of the survey.  178 
RESULTS  179 
A total of 1031 men completed the survey. Figure 1 shows self -reported lifetime testing 180 
history of HIV, syphilis, gonorrhea and chlamydia. In total, 294 (28.5%) men ever tested for 181 
chlamydia, 315 (30.6%) men ever tested for gonorrhea, 473 (45.9%) men tested for syphilis, 182 
and 817 (79.2%) men tested for HIV. The socio-demographic and behavioral characteristics 183 
of the total sample, respondents who ever tested for chlamydia and gonorrhea, are shown in 184 
Table 1. The majority were aged under 30 years (819, 79.4%), never married (907, 88.0%), 185 
had an annual personal income of 8500 USD or below (779, 75.6%), and obtained up to a 186 
college education (649, 62.9%). About a quarter reported condomless sex with either men or 187 
women in past three months.  188 
Over half of chlamydia (175, 59.5%) and gonorrhea (185, 58.7%) testers were living in 189 
Guangdong Province. The majority of chlamydia and gonorrhea testers were not students, 190 
had no children, self-identified as gay, and did not report condomless sex in past three 191 
months. Among chlamydia testers, 138 (46.9%) had any HIV testing, 92(31.3%) had facility-192 
based HIV testing, and 97(33.0%) had HIV self-testing in the past three months. Among 193 
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gonorrhea testers, 152(48.3%) had any HIV testing, 101(32.1%) had facility-based HIV 194 
testing, and 106(33.7%) had HIV self-testing in past three months. Up to 125 (42.5%) of 195 
chlamydia testers and 134 (42.5%) of gonorrhea testers had substantial community 196 
engagement.  197 
Compared to those who had never tested for gonorrhea or chlamydia, mean scores of HIV 198 
testing self-efficacy were significantly higher among those who had tested for chlamydia 199 
(3.26 vs 3.10, p<0.001) and gonorrhea (3.24 vs 3.10, p<0.001); anticipated HIV stigma mean 200 
scores were significantly lower among chlamydia (2.80 vs 2.91, p=0.02) and gonorrhea 201 
testers (2.81 vs 2.91, p=0.04) (Table 2). Multivariable logistic regression analyses showed 202 
that men living in Guangdong had higher odds of testing for chlamydia (adjusted odds ratio 203 
[AOR]= 1.6, 95%CI: 1.2-2.2) and gonorrhea (AOR=1.5, 95%CI: 1.1-2.0) compared to those 204 
who lived in Shandong (Table 3). The odds of testing for gonorrhea in men with high 205 
school/below education were 60% higher (AOR=1.6, 95%CI: 1.1-2.3) than those with 206 
university education or above.   207 
After controlling for demographic variables, those who had substantial community 208 
engagement were significantly more likely to report ever testing for chlamydia (AOR =2.8, 209 
95%CI: 1.9-4.3) and gonorrhea (AOR=2.9, 95%CI: 2.0-4.4), compared to men with no or 210 
minimal community engagement. Men with recent HIV testing were more likely to have 211 
received chlamydia testing (AOR=1.5, 95%CI: 1.1-2.0) and gonorrhea testing (AOR=1.6, 212 
95%CI: 1.2-2.1). Further, each point increase in the HIV testing self-efficacy mean score was 213 
associated with higher odds of chlamydia (AOR=1.9, 95%CI: 1.4-2.6) and gonorrhea testing 214 
(AOR=1.8, 95%CI: 1.3-2.4) respectively (Table 3).    215 
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DISCUSSION 216 
Chlamydia and gonorrhea are common STDs in China, but test uptake rates are low. We 217 
surveyed 1031 MSM in Guangdong and Shandong Provinces to analyze their 218 
chlamydia/gonorrhea testing history. This study extends the literature by examining 219 
chlamydia and gonorrhea testing uptake in a middle-income country. We found that less than 220 
one-third of men reported ever receiving a chlamydia or gonorrhea testing. 221 
Chlamydia/gonorrhea testing was associated with recent HIV testing and higher levels of 222 
community engagement.  223 
 224 
We found low levels of lifetime testing for chlamydia and gonorrhea in MSM in China. We 225 
examined chlamydia and gonorrhea testing at a single time point in two provinces only. The 226 
study findings may not be generalizable to the entire MSM population in the country. 227 
Additionally, a self-administered online survey may be subject to social desirability bias and 228 
men might not be familiar with chlamydia and gonorrhea. But our study provides a snapshot 229 
of testing behaviors for these often neglected STDs in an important Chinese subpopulation. 230 
Our test uptake rates were similar to previous reports from China,[14] and lower than test 231 
uptake rates from high-income country MSM.[15 16] Many more men received HIV and 232 
syphilis testing, compared to the number of men who received chlamydia/gonorrhea testing. 233 
This may be due to China’s focused efforts on HIV/syphilis prevention, without integration of 234 
chlamydia and gonorrhea testing services.[17] However, previous studies have shown that a 235 
substantial proportion of new HIV infections can be attributed to coinfection with chlamydia 236 
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or gonorrhea,[18 19] and screening for chlamydia/gonorrhea may be beneficial to the subset 237 
of MSM who are at higher risk of HIV acquisition.[20] To comprehensively address the HIV 238 
epidemic among MSM, there is a need for more attention to chlamydia/gonorrhea testing 239 
promotion in China.  240 
 241 
We also found that chlamydia/gonorrhea testing was significantly associated with substantial 242 
community engagement in sexual health. It is worth noting, however, that men with more 243 
community engagement and who have been tested are more likely to take the survey than 244 
their counterparts. Our test uptake rates are likely over-estimates. This trend is consistent with 245 
previous literature showing improved HIV and syphilis testing uptake among individuals 246 
with higher community engagement.[11] A recent quasi-experimental study in China also 247 
found that engaging MSM in STI testing programs significantly improved men’s dual 248 
chlamydia/gonorrhea test uptake.[21] There is currently a trend toward key population-led 249 
HIV prevention campaigns and strategies.[22-24] Integrating chlamydia and gonorrhea test 250 
promotion strategies into HIV prevention programs that engage MSM communities may help 251 
increase testing rates.  252 
 253 
Chlamydia/gonorrhea testing was significantly associated with recent HIV testing, including 254 
both facility-based and self-testing. This may be partly attributable to the extensive HIV 255 
testing system in China, which may serve as a gateway for MSM to improve awareness of 256 
STIs such as chlamydia and gonorrhea. Previous literature has explored the potential for 257 
integrated syphilis/HIV testing.[25-27] Given that there is already a relationship between 258 
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chlamydia/gonorrhea testing and HIV testing, incorporating chlamydia/gonorrhea testing 259 
with existing HIV testing services may be a promising strategy to increase test uptake. 260 
Nonetheless, our cross-sectional survey approach evaluated lifetime chlamydia and gonorrhea 261 
testing, and the analyses do not imply a causal relationship between HIV testing and 262 
chlamydia/gonorrhea testing. Further research is needed to examine potential effects of HIV 263 
testing behaviors on chlamydia and gonorrhea test uptake in China. 264 
CONCLUSION  265 
Compared to HIV and syphilis testing levels, chlamydia and gonorrhea testing rates in 266 
Chinese MSM are suboptimal. Few STI services are integrated into HIV prevention programs 267 
in China. We found that chlamydia and gonorrhea testing behaviors had a significant 268 
association with men’s community engagement in sexual health and their recent HIV testing. 269 
This suggests that integrating chlamydia and gonorrhea test promotion strategies into HIV 270 
prevention programs that engage MSM may be useful. 271 
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 369 
Figure 1: Percentage of MSM who reported to have ever tested for HIV, syphilis, gonorrhea, 370 
and chlamydia in 2017 in China (N=1031).  371 
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